Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2008 Results
Date:10/30/2008

vandapharma.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Various statements in this release are "forward-looking statements" under the securities laws. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," and "could," and similar expressions or words, identify forward- looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Vanda is at an early stage of development and may not ever have any products that generate significant revenue. Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: delays in the completion of Vanda's clinical trials; a failure of Vanda's product candidates to be demonstrably safe and effective; Vanda's failure to obtain regulatory approval for its products or to comply with ongoing regulatory requirements; a lack of acceptance of Vanda's product candidates in the marketplace, or a failure to become or remain profitable; Vanda's inability to obtain the capital necessary to fund its research and development activities; Vanda's failure to identify or obtain rights to new product candidates; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage its growth; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products under its license and sublicense agreements and other factors that are described in the "Risk Factors" section (Part II, Item 1A) of Vanda's quarterly report on Form 10-Q for the quarter ended June 30, 2008 (File No. 000-51863). In addition to the risks described above and in Part II, Item 1A of Vanda's quarterly report on F
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... PLANTATION, Fla. , July 18, 2014  Neurotrope, ... 2014,  its Board of Directors appointed Co-Chairmen Charles ... Co-Chief Executive Officers on an interim basis, effective immediately. ... , who is no longer Chief Executive Officer of ... or the Company and whose employment agreement with Neurotrope ...
(Date:7/18/2014)... CHICAGO, Ill. , July 18, 2014 ... an infographic highlighting AbbVie and Shire,s complementary ... combination. A copy of the ... website at:  http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-disclaimer-documents ... Takeover Code, a copy of this announcement ...
(Date:7/18/2014)... Provia Laboratories announces the addition of Dr. Jim ... Vaught has worked in the field of biorepository and ... of the founding members of ISBER – the International ... he served as its second president, and 15 years ... Vaught began working with the National Institutes of Health ...
(Date:7/17/2014)... Australia , July 17, 2014  Prana Biotechnology ... provided an update on its clinical development program for ... the Florey Institute of Neuroscience and Mental Health, The ... Phase 2 IMAGINE and EURO trials in his presentation ... Copenhagen, Denmark . The presentation is ...
Breaking Biology Technology:Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5
... Do the principles of quantum mechanics apply to biological ... Institute,s Chemical Physics Department (Faculty of Chemistry), both biologists ... to be like apples and oranges. But research he ... in Science , definitively shows that a biological ...
... China March 31, 2011 /PRNewswire-Asia/ -- Tiens Biotech Group (USA), ... ), a company dedicated to the research, development, ... and dietary supplements, today announced financial results for ... revenue was $41.3 million, compared to $62.0 million for 2009. ...
... March 31, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: ... developer, manufacturer and distributor of probiotics products in China, ... sales order from its newly signed U.S. customer. ... first sales order, and formally entered into its agreement ...
Cached Biology Technology:Biological molecules select their spin 2Tiens Biotech Group (USA) Reports 2010 Results 2Tiens Biotech Group (USA) Reports 2010 Results 3Tiens Biotech Group (USA) Reports 2010 Results 4Tiens Biotech Group (USA) Reports 2010 Results 5Tiens Biotech Group (USA) Reports 2010 Results 6Tiens Biotech Group (USA) Reports 2010 Results 7China-Biotics Receives First U.S. Sales Order 2China-Biotics Receives First U.S. Sales Order 3
(Date:7/22/2014)... SHELTON, Conn. , July 22, 2014 /PRNewswire/ ... on the growing m-commerce market, announces its next generation ... weekly 30-minute consumer oriented television show that airs ... Network. NewsWatch regularly features top ... on July 31st on the History Channel (6:00-6:30am ...
(Date:7/22/2014)... of immune cell widely believed to exacerbate chronic ... multiple sclerosis (MS), can actually protect the brain ... the progression of neurodegenerative diseases, according to Cleveland ... Nature Communications . , The research team, ... Department of Neurosciences at Cleveland Clinic,s Lerner Research ...
(Date:7/22/2014)... the the genus of planthopper known as Conosimus, which ... recently discovered in the southern part of the Iberian ... of it appears in the open-access Journal of ... new species, Conosimus baenai , has been named ... to the taxonomy of Iberian Hemiptera. , Conosimus ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3Cleveland Clinic researchers discover neuroprotective role of immune cell 2
... studies continue to validate the use of probiotics to ... for probiotics indicates that the U.S. healthcare community and ... microorganisms. However, because most probiotics are classified as dietary ... individual needs can be challenging. And, as the ...
... The Seventh Annual Symposium on Predictive Health, to ... on health and the human microbiome. The human microbiome ... and viruses, which reside throughout the body. Study ... attention across the United States, including a major federal ...
... of Atlantic salmon (Salmo salar), which have been ... new challenges in the Gulf of Maine, where ... new predators along altered migration routes are affecting ... in the journal Fisheries Management and Ecology, ...
Cached Biology News:As probiotics use grows for gut health, VSL#3 has designations for specific GI issues 2As probiotics use grows for gut health, VSL#3 has designations for specific GI issues 3Predictive health symposium will focus on human microbiome 2Environmental conditions and predators affect Atlantic salmon survival in the Gulf of Maine 2
...
... catalyzes the formation of phosphodiester bonds in ... with 3' hydroxyl and 5' phosphate termini. ... ligation which can be performed in 5 ... substrates for this enzyme. A T4 ...
Porcine Aortic Endothelial Cells (PAOEC) (>500,000 cells)...
Bovine Endometrium Epithelial Cells (BEnEpC) (>500,000 cells)...
Biology Products: